Ποια είναι η τιμή για Dallah Healthcare Company (4004)

Η τιμή για Dallah Healthcare Company (4004) είναι $26.85

Ποια είναι η κεφαλαιοποίηση αγοράς για Dallah Healthcare Company (4004)

Η κεφαλαιοποίηση αγοράς για Dallah Healthcare Company (4004) είναι $2.72B

Dallah Healthcare Company (4004) Τιμή και Κεφαλαιοποίηση Αγοράς

Operating within the Kingdom of Saudi Arabia, Dallah Healthcare Company specializes in delivering and managing a comprehensive array of healthcare services and infrastructure. Its core activities encompass the operation, management, outfitting, and growth of hospitals, various medical establishments, polyclinics, residential healthcare complexes, and associated land. Additionally, it supplies essential personnel and ancillary services to both hospitals and medical centers. Beyond direct healthcare provision, Dallah Healthcare is also involved in the production and supply of pharmaceutical, herbal, and cosmetic goods, distributing them to individual pharmacies, health and beauty retailers, hospitals, and government bodies. The firm further extends its expertise to include the oversight and running of hospitals belonging to external entities, alongside offering various supplementary support functions. This encompasses the administration of private hospitals, specialized medical and diagnostic centers, and an analytical laboratory, coupled with the direct provision of medical care. Originally established as Dallah Healthcare Holding Company, the organization officially adopted its current name, Dallah Healthcare Company, in November 2016. Founded in 1994, its corporate headquarters are situated in Riyadh, Saudi Arabia, and it operates as a subsidiary of Dallah Al-Barakah Holding.

Η τιμή για 4004	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$50,276.71 $2.72B	NVDA	$5.088T	+187,141.80%
$45,743.23 $2.72B	AAPL	$4.629T	+170,258.08%
$40,688.77 $2.72B	GOOG	$4.118T	+151,434.15%
$36,430.96 $2.72B	MSFT	$3.687T	+135,577.09%
$27,665.22 $2.72B	AMZN	$2.800T	+102,931.50%

Η τιμή για 4004

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$50,276.71 $2.72B